FDA Post-Market Safety Efforts Won’t Be Impacted By Sentinel In Near Term
Executive Summary
FDA's Sentinel post-market safety monitoring project will augment, not replace, the agency's current repertoire of post-market activities and requirements for drugs, Center for Drug Evaluation and Research Director Janet Woodcock emphasized
You may also be interested in...
Comparative Research Needs New Approach To Answer Real-Life Questions
To get the most out of the new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions so that it can answer real-world questions, two former CMS officials said at a recent forum at the American Enterprise Institute
Comparative Research Needs New Approach To Answer Real-Life Questions
To get the most out of the new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions so that it can answer real-world questions, two former CMS officials said at a recent forum at the American Enterprise Institute
Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance
WellPoint is exploring ways to more accurately identify adverse events as it builds a drug safety monitoring system.